Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 36, 2004 - Issue 2
Submit an article Journal homepage
31
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Progressive decrease of hepatitis B in a cohort of drug users followed over a period of 15 years: The impact of anti-HBV vaccination

Fabio Lugoboni From the Medical Service for Addictive Disorders, Department of Internal Medicine, University of Verona, ItalyCorrespondence[email protected]
,
Sabrina Migliozzi Public Health Authority Centre for Drug Users (PHCDU), Bussolengo, Verona, Italy
,
Paolo Mezzelani From the Medical Service for Addictive Disorders, Department of Internal Medicine, University of Verona, Italy
,
Benedetta Pajusco From the Medical Service for Addictive Disorders, Department of Internal Medicine, University of Verona, Italy
,
Raffaele Ceravolo Public Health Authority Centre for Drug Users (PHCDU), Bussolengo, Verona, Italy
&
Gianluca Quaglio From the Medical Service for Addictive Disorders, Department of Internal Medicine, University of Verona, Italy
Pages 131-133 | Received 15 Aug 2003, Accepted 20 Nov 2003, Published online: 11 Mar 2010

References

  • Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. N Engl J Med 1997; 336: 196–205.
  • Poovorawan Y, Chatchatee P, Chongsrisawat V Epidemiology and prophylaxis of viral hepatitis: a global prospective. J Gastroenterol Hepatol 2002; 17: 155–66.
  • Lamden KH, Kennedy N, Beeching NJ, Lowe D, Morrison CL, Mallison H, et al. Hepatitis B and hepatitis C virus infections: risk factors among drug users in north-west England. J Infect 1998; 37: 260–9.
  • Salleras L, Bruguera M, Buti M, Domingez A. Prospects for vaccination against hepatitis A and B in Catalonia. Vaccine 2000; 18: 80–2.
  • Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 to 1994. N Engl J Med 1999; 341: 556–62.
  • Bellentani S, Pozzato G, Saccoccio G, Crovatto M, Croce LS, Mazzoran L, et al. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut 1999; 44: 874–80.
  • Perez-Trallero E, Cilla G, Iturriza M, Garcia-Begoechea M, Peris A. Intravenous drug users: the only important reservoir of delta virus in Spain. J Infect Dis 1990; 161: 152.
  • Quaglio GL, Talamini G, Lechi A, Venturini L, Lugoboni F, Mezzelani P. Study of 2708 heroin-related deaths in northeastern Italy 1985–98 to establish the main causes of death. Addiction 2001; 96: 1127–37.
  • Lamagni TL, Davison KL, Hope VD. Poor hepatitis B vaccine coverage in IDUs, England 1995 and 1996. Comm Dis Public Health 1999; 2: 174–7.
  • Rumi M, Colombo M, Romeo R, Boschini A, Zanetti A, Gringeri A, Mannucci PM. Suboptimal response to hepatitis B vaccine in drug users. Arch Intern Med 1991; 151: 574–8.
  • Rodrigo JM, Serra MA, Aparisi L, Escudero A, Gilabert MWS, Garcia F, et al. Immune response to hepatitis B vaccine in parenteral drug abusers. Vaccine 1992; 10: 798–801.
  • Quaglio GL, Talamini G, Lugoboni F, Lechi A, Venturini L, Des Jarlais DC, Mezzelani P. Compliance with hepatitis B vaccination in 1175 heroin users and factors associated with lack of vaccine response. Addiction 2002; 97: 985–92.
  • Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research. Principles and Quantitative Methods. New York: Van Nostrand Reinhold Company, Inc.; 1982.
  • Mezzelani P, Venturini L, Fibbia GC, Perdona GP, Lugoboni F, Faccini M, et al. Parallel decline in both HIV and HBV seroprevalence following AIDS prevention programmes among injecting drug users in north-east Italy (abstract POC 4797). VIIIth International Conference on AIDS, Amsterdam 1992. Vancouver: Transcontinental Printing, Inc.
  • Ciaffoni S, Schiesari F, Lugoboni F. Annual incidence of HIV seropositivity in a cohort of IVDUs followed for 7 y. Vox Sang 1994; 67(S2): 107.
  • Lugoboni F, Migliozzi S, Schiesari, Pauletto N, Bovo L, Ciaffoni S, Mezzelani P. Immune response to hepatitis B vaccination campaign among injecting drug users. Vaccine 1997; 15: 1014–6.
  • Wong EK, Bodsworth NJ, Slade MA, Mulhall BP, Donovan B. Response to hepatitis B vaccination in a primary care setting: influence of HIV infection, CD4+ lymphocyte count and vaccination schedule. Int J STD AIDS 1996; 7: 490–4.
  • Brown SM, Stimmel B, Taub RN, Kochwa S, Rosenfield RE. Immunological dysfunction in heroin addicts. Arch Intern Med 1974; 134: 1001–6.
  • Winter AP, Follett EAC, McIntyre J, Stewart J, Symington I. Influence of smoking on immunological responses to hepatitis B vaccine. Vaccine 1994; 12: 771–2.
  • Wiedmann M, Liebert UG, Oesen U, Porst H, Wiese M, Schroeder S, et al. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology 2000; 31: 230–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.